140
Participants
Start Date
August 10, 2022
Primary Completion Date
September 25, 2024
Study Completion Date
September 25, 2024
Sitafloxacin
Oral administration, 50 mg tablets
Moxifloxacin Hydrochloride
Oral administration, 400 mg tablets
Peking University Shougang Hospital, Beijing
The First Affiliated Hospital of Dalian Medical University, Dalian
Huadong Hospital Affiliated To Fudan University, Shanghai
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Fuyang People's Hospital, Fuyang
Qilu Hospital of Shandong University, Jinan
Tianjin Medical University General Hospital, Tianjin
The Third Xiangya Hospital of Central South University, Changsha
The Sixth Hospital of Wuhan, Wuhan
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Henan Provincial People's Hospital, Zhengzhou
Nanfang Hospital Southern Medical University, Guangzhou
Shenzhen People's Hospital, Shenzhen
Affiliated Hospital of Guangdong Medical University, Zhanjiang
Gaozhou People's Hospital, Maoming
The Sixth People's Hospital of Chengdu, Chengdu
West China Hospital Sichuan University, Chengdu
The First Affiliated Hospital of Hebei North University, Zhangjiakou
Lead Sponsor
Daiichi Sankyo
INDUSTRY